BBIO
BridgeBio Pharma, Inc.
BBIO
BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BBIO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
BridgeBio Pharma, Inc. (BBIO) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Wall Street will get a series of fresh reads on the health of the U.S. consumer next week, with earnings from Walmart, Target, and Home Depot taking center stage during a relatively quiet stretch for
Next week brings another busy stretch for Wall Street, with investors set to digest a fresh round of earnings alongside several closely watched economic reports.
BridgeBio Pharma (BBIO) remains a "Strong Buy," driven by regulatory approvals, robust pipeline progress, and significant commercial momentum for Attruby in ATTR-CM. Company has achieved U.S. and inte